Noritate Cream
NDC Package 0187-5202-35
Package Information
Noritate (metronidazole) cream is a medication used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. This formulation utilizes a cream delivery system. Marketed by Bausch Health Us, Llc, this product is identified by NDC 0187-5202 and is authorized under FDA application NDA020743.
Identification & Billing
- RxCUI: 213120 - Noritate 1 % Topical Cream
- RxCUI: 213120 - metronidazole 10 MG/ML Topical Cream [Noritate]
- RxCUI: 213120 - Noritate 10 MG/ML Topical Cream
- RxCUI: 311680 - metroNIDAZOLE 1 % Topical Cream
- RxCUI: 311680 - metronidazole 10 MG/ML Topical Cream
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 0187 - Bausch Health Us, Llc
- 0187-5202 - Noritate
- 0187-5202-35 - 3.5 g in 1 TUBE
- 0187-5202 - Noritate
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (0187-5202). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 0187-5202-35 identifies a specific commercial package of 3.5 g in 1 tube of Noritate, a human prescription drug labeled by Bausch Health Us, Llc. This cream is formulated for topical use and contains metronidazole as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bausch Health Us, Llc on August 09, 2013. The current certification is valid through December 31, 2026.
What are the primary indications for this medication?
This medication is used on the skin to treat a certain skin disorder known as rosacea, a type of adult acne. It may help to decrease redness, swelling and the number of pimples caused by rosacea. This medication is an antibiotic. For the treatment of rosacea, metronidazole is believed to work by decreasing swelling (inflammation). Some brands of this medication also contain sunscreens (see also Notes section).
How is this Bausch Health Us, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 00187520235. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Labeler segment to maintain the 5-4-2 structure.